MSB 3.19% 97.0¢ mesoblast limited

Halabi throws a curve ball: Suggests correlation too small,...

  1. 375 Posts.
    lightbulb Created with Sketch. 298
    Halabi throws a curve ball: Suggests correlation too small, "only .38". "I'm still struggling on the whole issue of in vivo versus in vitro."

    SI responds: In vitro "It shows a strong correlation, as you have noted."
    In vivo: "You are correct, the in vivo correlation is not as strong" .. suggests largely used as a qualitative characteristic

    Halabi: it looks like a high MDS does not reflect the benefit here. (*throws curveball*

    Si Responds: I think you misinterpret the slide. (*hits it out of the park*)
    "In the three on the left, they represent the outcomes of (indiscernible) populations of patients treated with best available therapy today.
    *SI goes on to explain how he's saving lives and the correct interpretation of the slide.*

    Summarised: "We shift survival code of the patient of what would accepted to be 20 to 40% survival to 60% in six months."

    Halabi still not happy: "sample size still really small, follow up, you needed longer follow up"
    Halabi seems highly skeptical.
    Last edited by thisfool369: 14/08/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.